IDENTIFICATION OF A SOLUBLE IL-2 RECEPTOR BETA-CHAIN FROM HUMAN LYMPHOID-CELL LINE CELLS

被引:0
|
作者
HONDA, M
KITAMURA, K
TAKESHITA, T
SUGAMURA, K
TOKUNAGA, T
机构
[1] NATL INST HLTH,DEPT CELLULAR IMMUNOL,TOKYO 141,JAPAN
[2] TOHOKU UNIV,SCH MED,DEPT BACTERIOL,SENDAI,MIYAGI 980,JAPAN
来源
JOURNAL OF IMMUNOLOGY | 1990年 / 145卷 / 12期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A clone was isolated from the human lymphoid cell line YT that displayed IL-2R-beta, and was found to express much higher levels of IL-2R-beta than the original cells. Combining cell surface iodination, affinity labeling of the released soluble protein, and fluorescence sandwich-ELISA for both IL-2 and IL-2. (soluble)(s) IL-2R-beta reactants revealed the presence of IL-2-binding protein in the culture supernatant as soluble forms of IL-2R-beta. By using the fluorescence sandwich-ELISA elevated levels of sIL-2R-beta were measured in culture supernatants of human T cell leukemia virus I positive T cell lines. In addition to this constitutive production of sIL-2R-beta, normal PBMC could release low levels of IL-2R-beta by stimulation with PHA. In contrast, this was not found in certain human T cell leukemia virus I negative T cell, B cell and macrophage lines. Immunoprecipitation of the soluble protein with IL-2R-beta-specific mAb characterized it as an apparent 50- to 55-kDa molecule that is distinct from the 45-kDa soluble IL-2R-alpha. Moreover, 10 to 15% of the total cell surface molecules were release into culture supernatants. These results suggest that the released IL-2R-beta might serve as an immunoregulatory function in IL-2 dependent both normal and abnormal immune responses.
引用
收藏
页码:4131 / 4135
页数:5
相关论文
共 50 条
  • [1] CHEMOATTRACTANT ACTIVITY OF IL-2 FOR HUMAN-LYMPHOCYTES - A REQUIREMENT FOR THE IL-2 RECEPTOR BETA-CHAIN
    WILKINSON, PC
    NEWMAN, I
    IMMUNOLOGY, 1994, 82 (01) : 134 - 139
  • [2] THE IL-2 RECEPTOR ALPHA-CHAIN ALTERS THE BINDING OF IL-2 TO THE BETA-CHAIN
    ARIMA, N
    KAMIO, M
    OKUMA, M
    JU, G
    UCHIYAMA, T
    JOURNAL OF IMMUNOLOGY, 1991, 147 (10): : 3396 - 3401
  • [3] PROTEIN-PHOSPHORYLATION MEDIATED BY IL-2/IL-2 RECEPTOR BETA-CHAIN INTERACTION
    ISHII, T
    TAKESHITA, T
    NUMATA, N
    SUGAMURA, K
    JOURNAL OF IMMUNOLOGY, 1988, 141 (01): : 174 - 179
  • [4] TRANSFER AND EXPRESSION OF THE HUMAN IL-2 RECEPTOR BETA-CHAIN GENE IN MURINE FIBROBLASTS AND T-LYMPHOID CELLS USING RETROVIRAL VECTORS
    KRUPPA, G
    PFIZENMAIER, K
    SELIGER, B
    IMMUNOBIOLOGY, 1987, 175 (04) : 343 - 344
  • [5] LIGAND-BINDING BY THE IL-2 RECEPTOR IS MODULATED BY INTRACELLULAR DETERMINANTS OF THE IL-2 RECEPTOR BETA-CHAIN
    GOLDSMITH, MA
    AMARAL, MC
    GREENE, WC
    JOURNAL OF IMMUNOLOGY, 1995, 154 (05): : 2033 - 2040
  • [6] INTERLEUKIN (IL)-2 ACTIVATION OF P21RAS IN MURINE MYELOID CELLS TRANSFECTED WITH HUMAN IL-2 RECEPTOR BETA-CHAIN
    IZQUIERDO, M
    DOWNWARD, J
    OTANI, H
    LEONARD, WJ
    CANTRELL, DA
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (03) : 817 - 821
  • [7] SIGNAL-TRANSDUCTION MEDIATED BY THE RECONSTITUTED IL-2 RECEPTOR - EVIDENCE FOR A CELL-TYPE-SPECIFIC FUNCTION OF IL-2 RECEPTOR BETA-CHAIN
    MINAMI, Y
    OISHI, I
    LIU, ZJ
    NAKAGAWA, S
    MIYAZAKI, T
    TANIGUCHI, T
    JOURNAL OF IMMUNOLOGY, 1994, 152 (12): : 5680 - 5690
  • [8] A ROLE FOR CD-122 (IL2/IL15R BETA-CHAIN) IN THE REGULATION OF MURINE LYMPHOID-CELL DEVELOPMENT
    CARDING, SR
    TANNISHTHA
    BLOOD, 1994, 84 (10) : A434 - A434
  • [9] UTILIZATION OF THE BETA-CHAIN AND GAMMA-CHAIN OF THE IL-2 RECEPTOR BY THE NOVEL CYTOKINE-IL-15
    GIRI, JG
    AHDIEH, M
    EISENMAN, J
    SHANEBECK, K
    GRABSTEIN, K
    KUMAKI, S
    NAMEN, A
    PARK, LS
    COSMAN, D
    ANDERSON, D
    EMBO JOURNAL, 1994, 13 (12): : 2822 - 2830
  • [10] MONOCLONAL-ANTIBODIES DEFINING DISTINCT EPITOPES OF THE HUMAN IL-2 RECEPTOR BETA-CHAIN AND THEIR DIFFERENTIAL-EFFECTS ON IL-2 RESPONSES
    OHBO, K
    TAKESHITA, T
    ASAO, H
    KURAHAYASHI, Y
    TADA, K
    MORI, H
    HATAKEYAMA, M
    TANIGUCHI, T
    SUGAMURA, K
    JOURNAL OF IMMUNOLOGICAL METHODS, 1991, 142 (01) : 61 - 72